← Back
$BIOA All transactions

BioAge Labs, Inc.

▼ SELL 10b5-1 Plan

$ Value

$240K

Shares

11,663

Price

$21

Filed

Jan 15

Insider

Name

GOLDSTEIN DOV A MD

Title

Chief Financial Officer

CIK

0001120478

Roles

Officer

Transaction Details

Transaction Date

2026-01-13

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

24,331

Footnotes

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2024. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.91 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 through 5 of this Form 4. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.00 to $19.86 per share, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.04 to $21.02 per share, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.04 to $21.15 per share, inclusive. | The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on May 17, 2024, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. Additionally, the entire award is exercisable at any time pursuant to an early exercise feature of the option award.

Filing Info

Accession No.

0001120478-26-000003

Form Type

4

Issuer CIK

0001709941

GOLDSTEIN DOV A MD's History

Date Ticker Type Value
2026-03-01 BIOA M $16K
2026-03-01 BIOA M $0
2026-02-17 BIOA A $0
2026-02-01 BIOA M $16K
2026-02-01 BIOA M $0
2026-01-16 BIOA M $16K
2026-01-16 BIOA M $0
2026-01-13 BIOA M $227K
2026-01-13 BIOA $165K
2026-01-13 BIOA $86K

Other Insiders at BIOA (90d)

Insider Bought Sold Last
GOLDSTEIN DOV A MD
Chief Financial Officer
2026-03-01
RUBIN PAUL D
Chief Medical Officer
$447K 2026-04-01
Barton Shane
Principal Accounting Officer
2026-02-17
Fortney Kristen
Chief Executive Officer
2026-02-17
Morgen Eric
Chief Operating Officer
2026-02-17